Novartis AG
Novartis AG
NVS
Valuace
43
Růst
71
Zdraví
83
Cena
$ 126.72
Dnes
+1.19 (0.83%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
247.9B
Obrat
56B
Zisk
14B
Aktiva
107B
Dluh
32B
ROE
0%
ROA
0%
PE
22
PS
6
Cena 1R
98-146
⌀ Cena
123.15
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
28-04-2026
Poslední dividenda
11-03-2026

Profil

Společnost Novartis AG provádí výzkum, vývoj, výrobu a prodej zdravotnických produktů po celém světě. Společnost působí ve dvou segmentech, Inovative Medicines a Sandoz. Segment Inovativní léčiva nabízí léky na předpis pro pacienty a poskytovatele zdravotní péče. Poskytuje také oftalmologii, neurovědu, imunologii, hepatologii, dermatologii, respirační, kardiovaskulární, renální a metabolické léčivé přípravky. Segment Sandoz vyvíjí, vyrábí a prodává hotové lékové formy; účinné látky a hotové lékové formy malých molekul třetím stranám; maloobchodní generika a antiinfekční prostředky. Zajišťuje také účinné farmaceutické složky a meziprodukty, především antibiotika, bílkovinné a jiné biotechnologické produkty, včetně biosimilarů, a biotechnologické výrobní služby. Společnost Novartis AG uzavřela licenční smlouvu a smlouvu o spolupráci se společností Alnylam Pharmaceuticals na vývoj, výrobu a komercializaci inclisiranu a klinickou spolupráci se společností Kura Oncology, Inc. na hodnocení kombinace tipifarnibu a alpelisibu u pacientů s dlaždicobuněčným karcinomem hlavy a krku. Společnost byla založena v roce 1996 a sídlí ve švýcarské Basileji.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
75883
Založení
1996-11-07
Adresa
Lichtstrasse 35
CEO
Vasant Narasimhan

Podobné společnosti

$ 86.08
+ $ 1.50
$ 46.75
+ $ 0.12
$ 50.17
+ $ 0.51
$ 86.23
- $ 0.05
$ 187.28
+ $ 0.71

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues56.1554.8151.7246.6651.8352.8849.9048.6853.1750.1449.4450.3953.6358.8357.5659.3851.56
Cost of Revenues13.6313.6912.8312.4715.4915.8715.1214.4318.4117.1817.5217.4017.3519.6118.7618.9814.49
Gross Profit42.5241.1238.9034.1936.3437.0134.7834.2534.7632.9631.9232.9836.2939.2238.8140.3937.07
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues13.3314.3614.8413.6213.5613.1712.8712.1211.7812.09
Cost of Revenues3.543.543.323.233.323.233.173.103.023.12
Gross Profit9.7910.8211.5110.3910.239.949.709.028.758.98
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.0011.3710.009.548.989.409.078.979.048.949.099.859.339.589.07
Selling General & Admin Expenses0.000.000.0012.4914.2514.8914.2014.3716.4715.0014.1914.2514.9917.6117.2918.0515.80
Depreciation & Amortization5.325.356.078.287.196.117.066.536.896.086.045.584.754.994.955.793.42
Total Operating Expenses24.9724.0524.3524.4227.1525.3224.6325.1726.5924.3323.6524.0125.2028.3127.2929.3925.55
Operating Income17.5517.0714.549.779.2026.9510.159.098.178.638.278.9811.0910.9111.5111.0011.53
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.002.573.93
Selling General & Admin Expenses0.000.000.000.000.000.000.000.003.443.09
Depreciation & Amortization1.551.361.261.151.631.971.161.311.593.11
Total Operating Expenses6.276.326.655.736.706.315.695.656.177.21
Operating Income3.524.504.864.663.533.634.013.372.581.76
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.000.370.570.630.380.070.090.250.290.110.040.030.030.030.050.060.10
Interest Expense1.151.191.040.860.840.810.870.850.960.780.710.660.700.680.720.750.69
Other Expense-1.20-0.64-0.90-0.65-0.83-0.81-0.27-0.156.371.060.230.271.920.600.550.500.80
IBT16.3516.4413.649.128.3726.149.888.9413.849.007.828.1312.2710.7411.2410.7711.70
Income Tax Expense2.382.401.700.551.422.121.811.791.221.301.121.111.551.441.631.531.73
Net Income13.9814.0611.9414.856.9624.028.077.1512.617.706.7117.7810.219.189.519.119.79
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.000.000.000.000.000.000.410.22
Interest Expense0.300.280.290.270.270.270.250.220.220.22
Other Expense-0.30-0.31-0.33-0.26-0.25-0.24-0.17-0.24-0.21-0.21
IBT3.224.204.534.413.293.393.843.132.381.55
Income Tax Expense0.810.270.510.800.470.200.600.44-0.260.04
Net Income2.413.934.043.612.823.193.252.698.481.76
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$7.15$3.19$10.71$3.55$3.12$5.44$3.28$2.82$7.40$4.21$3.76$3.93$3.75$4.28
EPS Diluted$0.00$0.00$0.00$7.10$3.17$10.63$3.52$3.08$5.38$3.25$2.80$7.29$4.13$3.70$3.89$3.70$4.26
Shares Outstanding1.911.942.022.082.182.242.282.292.322.352.382.402.432.442.422.382.29
Diluted Shares Outstanding1.931.962.042.092.202.262.302.322.342.372.402.442.472.482.442.412.30
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.14$0.85
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.11$0.85
Shares Outstanding1.911.931.951.971.992.012.032.042.052.06
Diluted Shares Outstanding1.931.941.961.982.002.032.052.062.072.08
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents7.9011.4613.397.5212.419.6611.1113.278.867.014.6713.026.695.553.715.32
Short Term Investments0.531.890.5711.4115.921.910.332.690.630.770.770.842.542.571.372.82
Total Cash & ST Investments8.4413.3513.9618.9328.3311.5611.4515.969.497.785.4513.869.228.125.088.13
Accounts Receivable8.489.548.128.338.288.468.5611.0211.1010.208.188.289.9010.0512.3711.72
Inventory5.755.725.917.186.677.135.986.966.876.266.236.097.276.745.936.09
Other Current Assets3.031.092.022.472.442.522.681.620.760.702.992.533.393.090.712.59
Total Current Assets25.6929.7030.4836.9145.7229.6729.5035.5628.2124.9322.8537.5630.5428.0024.0826.69
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents9.566.667.0711.4613.617.909.4713.3912.4110.89
Short Term Investments0.200.340.131.890.410.530.230.570.290.29
Total Cash & ST Investments9.757.007.2013.3514.028.449.6913.9612.7011.17
Accounts Receivable8.989.188.739.548.158.488.258.127.109.54
Inventory6.426.315.835.725.945.755.745.915.618.23
Other Current Assets3.043.463.361.093.163.032.763.3920.264.55
Total Current Assets28.2025.9425.1129.7031.2625.6926.4530.4845.6633.49
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment10.6210.8710.9212.2013.1113.9413.7515.7016.4615.6415.9815.9818.2016.9415.6315.84
Goodwill25.2324.7623.3429.3029.6030.0026.5235.2931.7530.9831.1729.3131.0331.0929.9429.69
Intangible Assets27.7826.9226.8831.6434.1836.8128.7938.7230.0031.3434.2223.8327.8430.3331.9735.23
Long-Term Investments2.131.131.832.553.2412.5311.1610.7017.6116.5027.3418.7018.6517.859.609.24
Other Long-Term Assets1.664.512.181.112.210.890.740.900.820.70-8.96-7.99-7.38-7.390.421.39
Total Long-Term Assets71.8172.5469.4680.5486.08102.3988.87110.00104.87105.19108.7187.8395.7196.2193.4196.63
Total Assets97.51102.2599.95117.45131.80132.06118.37145.56133.08130.12131.56125.39126.25124.22117.50123.32
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment11.9911.8311.0910.8711.2010.6210.5410.9210.3412.28
Goodwill25.5525.5524.9724.7624.9325.2323.0623.3423.4229.52
Intangible Assets29.0429.2427.4826.9227.9027.7826.2726.8826.4228.00
Long-Term Investments2.152.162.101.132.192.132.581.832.122.43
Other Long-Term Assets4.784.474.114.511.391.661.212.181.111.21
Total Long-Term Assets79.0978.4674.8372.5472.2671.8167.8969.4667.0477.49
Total Assets107.29104.4099.94102.25103.5297.5194.3399.95112.70110.98
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable4.154.574.935.155.555.405.425.565.174.875.675.426.155.594.994.79
Short-Term Debt7.768.326.316.186.5710.077.289.625.205.915.606.616.785.956.348.58
Other Current Liabilities13.7813.4412.6417.2117.9617.5315.4514.2012.7311.1412.0514.6113.3712.4411.7511.21
Current Liabilities27.6128.6926.3928.6630.2133.0628.2629.6123.4022.2123.7126.9726.3724.0523.1524.66
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable4.564.514.264.574.094.154.064.933.875.35
Short-Term Debt7.788.578.048.326.817.768.566.315.678.54
Other Current Liabilities16.3215.8119.3213.4415.0713.7815.0112.6436.73-20.61
Current Liabilities32.0031.7131.6228.6928.1327.6129.2926.3948.3931.91
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt19.6622.9320.0321.7824.5227.9822.0622.4723.2217.9016.3313.8011.2413.7813.8614.36
Capital Leases1.561.801.831.791.902.011.950.000.000.000.000.000.000.000.000.00
Def. Tax Liability2.462.422.252.693.077.425.877.485.176.666.366.106.907.296.767.69
Total Liabilities55.6058.1253.2058.0363.9775.3962.8266.8758.8555.2354.4354.5451.7855.0051.5653.55
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt24.2424.0623.2322.9325.3521.2218.7220.0319.5219.80
Capital Leases1.901.851.801.801.841.791.751.831.661.79
Def. Tax Liability2.172.322.552.422.222.462.312.252.462.53
Total Liabilities62.5462.3461.4958.1260.0855.6054.5853.2074.4559.05
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.790.790.830.890.900.910.940.940.970.970.991.001.001.001.020.96
Retained Earnings45.8446.5649.650.000.000.000.000.000.000.000.000.000.000.0064.9562.36
Comprehensive Income-4.87-3.25-3.7758.5466.8055.7454.6277.7473.3073.9476.1669.8773.4368.1864.9562.36
Total Common Equity41.7344.0546.6759.3467.6656.6055.4778.6174.1774.8377.0570.7774.3469.0965.8463.20
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.770.770.770.790.790.790.790.830.830.84
Retained Earnings43.5141.5339.8446.5646.2945.8443.8349.6542.3355.68
Comprehensive Income0.10-0.27-2.23-3.25-3.74-4.89-4.9145.88-4.9651.06
Total Common Equity44.3341.9938.3744.0543.3241.7339.6846.6738.1651.85
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt28.9931.2626.3527.9631.0938.0529.3332.0928.4323.8021.9320.4118.0219.7320.2022.94
Book Value41.9044.1346.7559.4267.8256.6755.5578.6974.2374.8977.1270.8474.4769.2265.9469.77
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.420.070.080.080.120.170.080.080.080.08
Book Value44.3341.9938.3744.0543.3241.7339.6846.6738.1651.85
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income10.0914.0611.948.576.9624.028.077.1512.617.706.707.0310.739.299.629.259.97
Depreciation & Amortization7.185.356.078.287.186.116.465.836.896.086.045.584.754.994.955.793.42
Stock-Based Compensation0.970.001.040.870.820.740.740.760.760.680.670.770.740.730.750.790.66
Change Working Capital-1.59-3.08-0.71-0.37-1.000.24-0.290.200.500.24-0.08-0.86-0.63-0.74-0.14-0.111.76
Change In Accounts Receivable-1.78-1.13-0.93-1.50-0.59-0.390.14-0.98-0.57-0.20-0.23-0.51-0.37-0.410.37-0.730.03
Change In Accounts Payable-0.17-0.27-0.110.48-0.05-0.02-0.320.550.310.06-0.590.380.140.500.520.200.49
Change In Inventories-0.150.03-0.23-0.55-0.830.08-0.54-0.38-0.53-0.25-0.24-0.48-0.51-0.65-0.700.050.97
Other Non-cash Items6.233.27-2.43-3.44-1.14-18.16-3.14-2.10-7.71-3.38-2.98-1.72-3.25-2.54-2.61-2.93-3.47
Cash from Operations15.070.000.0014.4614.2415.0713.6513.6314.2712.6211.4811.9013.9013.1714.1914.3114.07
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income2.413.934.023.612.823.193.252.692.641.51
Depreciation & Amortization1.551.361.261.151.631.971.161.311.593.11
Stock-Based Compensation0.000.270.270.260.270.260.260.260.250.21
Change Working Capital-2.291.340.44-1.770.010.820.24-1.99-0.381.18
Change In Accounts Receivable-0.090.18-0.17-1.040.160.33-0.50-0.92-0.24-0.12
Change In Accounts Payable0.10-0.06-0.14-0.170.56-0.11-0.14-0.410.56-0.18
Change In Inventories0.15-0.13-0.040.06-0.170.09-0.02-0.130.03-0.03
Other Non-cash Items0.59-0.590.17-0.40-1.00-0.15-0.62-0.45-1.28-0.67
Cash from Operations0.000.000.000.000.000.000.000.002.555.38
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-3.35-3.92-1.37-2.75-2.67-2.97-2.59-2.26-3.36-2.75-2.88-3.85-3.70-3.78-3.31-2.39-2.23
Acquisitions-7.02-3.01-3.83-3.57-0.9020.10-9.96-3.77-1.07-0.76-0.77-16.51-0.33-0.04-1.74-0.58-26.67
Investments-0.94-0.30-3.65-0.76-34.82-16.59-2.13-0.53-2.70-1.05-0.78-0.86-0.41-0.44-1.12-1.94-40.71
Sales of Investment2.122.193.7011.6039.492.741.223.710.640.880.870.432.520.560.743.4153.27
Other Investing Activities0.680.000.001.080.370.930.280.610.900.550.1110.012.810.34-0.240.700.58
Cash from Investing-8.080.000.005.601.474.21-13.18-2.23-5.59-3.12-3.44-10.780.88-3.35-5.68-0.79-15.76
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-1.02-0.35-0.33-0.25-0.56-0.32-0.26-0.23-0.78-0.68
Acquisitions-1.17-0.16-1.680.01-0.26-0.05-3.33-0.26-0.01-3.45
Investments-0.08-0.10-0.06-0.06-2.31-1.01-0.28-0.05-0.57-0.04
Sales of Investment0.070.180.051.880.581.471.080.570.180.29
Other Investing Activities0.000.000.000.000.000.000.000.00-0.571.67
Cash from Investing0.000.000.000.000.000.000.000.00-1.76-2.21
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-4.880.000.00-1.68-2.87-2.48-2.32-3.47-0.37-0.19-1.70-3.09-2.60-2.02-0.70-0.03-0.01
Debt Issued5.5331.264.910.06-0.26-4.4811.030.714.034.813.574.614.990.310.23-2.7222.95
Issuance of Common Stock0.020.000.000.000.00-3.4610.091.975.244.433.975.055.920.690.410.160.73
Repurchase of Common Stock-5.59-9.26-8.33-8.72-10.65-3.06-2.84-5.53-2.04-5.49-1.11-4.49-4.52-1.24-0.09-3.63-0.31
Dividends Paid-7.620.000.00-7.26-7.51-7.37-6.99-6.65-6.97-6.50-6.48-6.64-6.81-6.10-6.03-5.37-4.49
Other Financing Activities4.310.000.003.370.470.09-0.150.05-0.110.010.000.00-0.14-0.10-0.26-6.168.19
Cash from Financing-9.800.000.00-14.28-20.56-16.26-2.21-13.63-4.24-7.73-5.31-9.18-8.15-8.77-6.68-15.024.12
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.61-2.29
Debt Issued32.02-0.621.370.01-0.903.171.700.941.77-0.87
Issuance of Common Stock0.000.000.000.000.000.000.000.000.000.00
Repurchase of Common Stock-1.48-2.30-2.71-2.72-2.76-2.85-1.62-1.10-1.25-1.63
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.000.033.08
Cash from Financing0.000.000.000.000.000.000.000.00-0.61-0.83
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-2.98-0.02-1.935.88-4.892.75-1.45-2.164.411.852.33-8.356.341.141.84-1.612.43
Closing Cash Balance7.9011.4411.4613.397.5212.419.6611.1113.278.867.014.6713.026.695.553.715.32
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash1.882.90-0.41-4.39-2.155.71-1.57-3.920.991.52
Closing Cash Balance11.449.566.667.0711.4613.617.909.4713.3912.41
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow11.7217.6913.8111.7111.5712.1011.0711.3710.929.888.608.0510.199.4010.8911.9211.84
Real Free Cash Flow10.7517.6912.7610.8410.7411.3610.3310.6110.169.197.937.279.458.6710.1411.1311.18
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow1.645.746.112.153.065.494.151.111.764.70
Real Free Cash Flow1.645.475.841.892.795.233.890.851.524.49
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E22.219.286.1
P/S5.53.8578
P/B6.93.2582.9
P/FCF20.917.610581.1
Market cap$247.9$215.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %22.4 %0 %
Debt to Income229 %280.5 %0 %
Debt to Free cash flow215.7 %40.7 %0 %
Interest expense percentage6.5 %7.6 %7 %
Current ratio0.9 1.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE31.5 %18.6 %0 %
ROA13 %9.1 %0 %
CapEx to Revenue3.5 %5.5 %10.5 %
RaD to Revenue0 %17.5 %0 %
ROEM739,941.6 95615855.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin75.7 %69.1 %77.7 %
Operating margin31.3 %20.4 %29.4 %
Net margin24.9 %21.9 %22.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %3.5 %0 %
Dividend payout percentage0 %66.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding1,929.0 mil 2,297.7 mil
Employee count75.9 tis 96.5 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader